NCT07429669

Brief Summary

Interscalene block is widely accepted as the gold-standard regional analgesic technique for pain control after arthroscopic shoulder surgery. However, because this block is performed at the level of the brachial plexus roots, it may be associated with adverse effects such as phrenic nerve blockade and subsequent diaphragmatic dysfunction. These limitations have prompted the search for alternative regional anesthesia techniques that can provide effective postoperative analgesia while preserving respiratory function. The anterior suprascapular block, which covers a broad dermatomal distribution of the shoulder region, has been shown in some studies to provide sufficient analgesia as a standalone technique. In addition, the pericapsular nerve group (PENG) block of the shoulder-applied around the anterior capsule and performed at a distance from critical neurovascular structures that may lead to serious complications-may represent another potential analgesic option following arthroscopic shoulder procedures. Therefore, this study aims to evaluate alternative regional block techniques in comparison with the interscalene block and to contribute to the identification of an optimal analgesic strategy after arthroscopic shoulder surgery.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P75+ for not_applicable postoperative-pain

Timeline
5mo left

Started Feb 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress40%
Feb 2026Nov 2026

First Submitted

Initial submission to the registry

February 13, 2026

Completed
10 days until next milestone

Study Start

First participant enrolled

February 23, 2026

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 24, 2026

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 10, 2026

Expected
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2026

Last Updated

February 24, 2026

Status Verified

February 1, 2026

Enrollment Period

9 months

First QC Date

February 13, 2026

Last Update Submit

February 23, 2026

Conditions

Keywords

Interscalene blockAnterior suprascapular blockPericapsular nerve group blockShoulder BlockArthroscopic shoulder surgeryPain, acutePain, Postoperative

Outcome Measures

Primary Outcomes (1)

  • Pain scores

    Pain will be assessed at rest and while coughing using the visual analog scale on a scale from 0 (no pain) to 100 (worst pain) at the first postoperative hour.

    First hour after the surgery

Secondary Outcomes (4)

  • Pain scores

    First 24 hours after surgery

  • Forced vital capacity (FVC) (volume)

    Perioperative period

  • Forced expiratory flow in 1 s (FEV1) (volume)

    Perioperative period

  • FEV1/FVC

    Perioperative period

Study Arms (3)

Interscalene block

ACTIVE COMPARATOR

In the preoperative period, 10 mL of 0.25% bupivacaine will be injected between C5 and C6 using an in-plane technique guided by a linear ultrasound (US) probe.

Procedure: Interscalene block

Anterior suprascapular block

ACTIVE COMPARATOR

A linear ultrasound probe will be positioned in the supraclavicular fossa, parallel to the clavicle. The suprascapular nerve will be identified as a hyperechoic oval structure deep to the omohyoid muscle and posterior-lateral to the brachial plexus. 10 mL of local anesthetic will be injected under the omohyoid muscle, around the suprascapular nerve.

Procedure: Anterior suprascapular block

Pericapsular nerve group (PENG) block

ACTIVE COMPARATOR

A linear ultrasound probe will be placed sagittally, near the axillary region, just below the coracoid process. The subscapularis muscle and its tendon will be visualized. The target area is the space between the deep fascia of the subscapularis muscle and the anterior surface of the shoulder joint capsule. The needle will pass the subscapularis muscle and be guided into the plane between the capsule and the muscle, where 20 mL of local anesthetic will be dispensed to block the articular branches innervating the capsule.

Procedure: Pericapsular nerve group (PENG) block

Interventions

Interscalene block will be performed, under US guidance, before the surgical operation, and when the patient is placed in the supine position.

Interscalene block

Anterior suprascapular block will be performed, under US guidance, before the surgical operation, and when the patient is placed in the supine position.

Anterior suprascapular block

Pericapsular nerve group (PENG) block will be performed, under US guidance, before the surgical operation, and when the patient is placed in the supine position.

Pericapsular nerve group (PENG) block

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with ASA scores I-II-III
  • Patients scheduled for elective arthroscopic shoulder surgery
  • Patients who have been informed about the study and have given written consent will be included.

You may not qualify if:

  • Those with a known allergy to local anesthetics
  • Those with an infection at the application site
  • Those with a severe coagulopathy disorder or anticoagulant use
  • Those with contralateral phrenic nerve palsy or a serious pulmonary diagnosis
  • Those with a history of chronic opioid use or neuropathic pain

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Etlik City Hospital

Yenimahalle, Ankara, 06170, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Pain, PostoperativeAcute Pain

Interventions

Dental Occlusion

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

DentistryDental Physiological PhenomenaDigestive System and Oral Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal İnvestigator

Study Record Dates

First Submitted

February 13, 2026

First Posted

February 24, 2026

Study Start

February 23, 2026

Primary Completion (Estimated)

November 10, 2026

Study Completion (Estimated)

November 30, 2026

Last Updated

February 24, 2026

Record last verified: 2026-02

Locations